Method for NGF assay for in vitro diagnosis of breast cancer and therapeutic use
US7618790B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Oct 28, 2003 |
| Grant date | Nov 17, 2009 |
| Priority date | — |
| Expiry date | Oct 28, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns a method for the in vitro diagnosis of breast cancer which consists in determining the presence of NGF in a biological sample derived from a patient suspected of suffering from breast cancer. Said method may be used both in early diagnosis, screening, therapeutic follow-up and prognosis, and in the diagnosis of relapse in the case of breast cancer.The present invention also concerns the use of an NGF binding partner or of an NGF inhibitor for preparing a medicinal product, said medicinal product being in particular useful for blocking tumor proliferation and remote dissemination in patients suffering from breast cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.